Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Umama Yezdani"'
Autor:
Hani Alothaid, Mohammed S. Aldughaim, Azeez Oriyomi Yusuf, Umama Yezdani, Alaa Alhazmi, Mahmoud M. Habibullah, Mohammad Gayoor Khan
Publikováno v:
Drug Delivery, Vol 28, Iss 1, Pp 2119-2126 (2021)
Albendazolum (ABZ) is a BCS class II drug. It has challenging biopharmaceutical properties, which include poor solubility and dissolution rate. These properties have laid the ground for developing a supersaturated self-nanoemulsifying drug delivery s
Externí odkaz:
https://doaj.org/article/4837e5bbf5534906b19573c605748185
Autor:
Ikechukwu Otuosorochi Amagwula, Chijioke M. Osuji, Chinenyenwa Gloria Omeire, Umama Yezdani, Mohammad Gayoor Khan, Chinaza Godswill Awuchi
Publikováno v:
Biogenesis: Jurnal Ilmiah Biologi. 10
Autor:
Mohammad Gayoor Khan, Hani Alothaid, Saad Saeed Alamri, Mahmoud Habibullah, Umama Yezdani, Mazen M. Ghaith
Publikováno v:
Case Reports in Clinical Medicine. 10:99-107
Background: Breast lymphomas are typical extranodal types of lymphoma, also known as Extranodal-lymphoma (ENL), which occur extremely infrequently, aggregating into a very small proportion of malignant breast tumors. The rarity of breast lymphomas is
Autor:
Umama Yezdani, Mohammad Gayoor Khan, Shumaila Yousuf, Shareefa Habeeba, Nausheen Sehar, Noor Us Sabah, Rafya Fatima
Publikováno v:
Asian Journal of Pharmaceutical Research and Development. 8:117-122
Chronic kidney disease (CKD) is a global public health problem affecting the adult population in several continents and increasing the risk of adverse outcomes. This prospective study has been conducted to understand the evidence based pharmacotherap
Autor:
Mohammad Gayoor Khan, Aarti Singh Kushwah, Sabitha Mary Kurian, M Thangapandi, Veena Suresh, Umama Yezdani, D. Nagendra Babu
Publikováno v:
International Journal of Current Research and Review. 12:61-72
Autor:
Alaa Alhazmi, Mohammad Gayoor Khan, Mahmoud Habibullah, Azeez Yusuf, Umama Yezdani, Mohammed S. Aldughaim, Hani Alothaid
Publikováno v:
Drug Delivery
article-version (VoR) Version of Record
Drug Delivery, Vol 28, Iss 1, Pp 2119-2126 (2021)
article-version (VoR) Version of Record
Drug Delivery, Vol 28, Iss 1, Pp 2119-2126 (2021)
Albendazolum (ABZ) is a BCS class II drug. It has challenging biopharmaceutical properties, which include poor solubility and dissolution rate. These properties have laid the ground for developing a supersaturated self-nanoemulsifying drug delivery s
Publikováno v:
Asian Journal of Pharmaceutical Research and Development. 7:84-88
The current situation of Malignant Neoplasm is very different it’s the fourth decade and despite much progress has been made in categorizing the environmental causes and cellular and molecular biological basis for this dreaded disease, Malignant Ne
Autor:
Shourabh Rav, Shayam singh Maina, Rachna Malviya, Madan Gopal Kushwah, Mohammad Gayoor khan, Umama Yezdani
Publikováno v:
International Journal of Pharmaceutical Research and Development. 1:19-22
Publikováno v:
Bangladesh Journal of Medical Science.
The clinical range of Covid-19 is a respiratory route infection that varies from Asymptomatic to various clinical conditions such as respiratory failure to multiple organ dysfunction syndromes (MODS). Government administration officials are ramping u